Skip to content
Screener

Aspire Biopharma Holdings ASBP Q3 2025 earnings

Reported November 14, 2025 · Before market open

Revenue$1.9K
EPS-$1.60

Next report

Date not yet announced

FAQ

When did Aspire Biopharma Holdings report Q3 2025 earnings?
Aspire Biopharma Holdings (ASBP) reported Q3 2025 earnings on November 14, 2025 before market open.
What were Aspire Biopharma Holdings's Q3 2025 revenue and EPS?
Aspire Biopharma Holdings reported revenue of $1.9K and eps of $-1.60 for Q3 2025.
How did Aspire Biopharma Holdings's Q3 2025 results compare year-over-year?
Compared to the same quarter a year prior, eps declined 9153.9% from $-0.02.
Where can I find Aspire Biopharma Holdings's Q3 2025 SEC filings?
You can read the 8-K earnings release (0001493152-25-022580) and the 10-Q/A periodic report (0001493152-25-023619) directly on SEC EDGAR. The filing index links above go to sec.gov.